Mabwell (shanghai) Bioscience Co., Ltd.
Clinical trials sponsored by Mabwell (shanghai) Bioscience Co., Ltd., explained in plain language.
-
First human test of new drug for asthma, COPD, and skin condition
Knowledge-focused CompletedThis was an early-stage study to check the safety of a new injection called 9MW1911 in healthy people. The main goal was to see how well the body tolerated the drug and to find the highest safe dose. Researchers also measured how long the drug stayed in the body and if it trigger…
Phase: PHASE1 • Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
First humans dosed in early trial for future fibrosis and cancer drug
Knowledge-focused CompletedThis was the first time a new drug called 9MW3811 was given to people. The main goal was to check if it was safe and how the body handled it in 32 healthy adult volunteers. This early safety study is a necessary first step before testing if the drug can help treat conditions like…
Phase: PHASE1 • Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC